---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-106095"
form_type: "8-K"
ticker: "TXMD"
cik: "0000025743"
company_name: "TherapeuticsMD, Inc."
filed_at: "2024-12-05T23:59:59+00:00"
generated_at: "2026-05-29T07:30:18.305095+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# TherapeuticsMD annual meeting votes: all director nominees elected, say-on-pay approved, auditor ratified

## Summary
- All four board nominees elected: Thompson 4.60M for, Collins 4.73M, Naughton 4.64M, Roberts 4.63M; broker non-votes 1.97M each.
- Non-binding advisory vote on 2023 exec comp: 4.61M for, 218K against, 30K abstain; broker non-votes 1.97M.
- Ratification of Berkowitz Pollack Brant as auditor for FY2024: 6.44M for, 383K against, 12K abstain; no broker non-votes.
- Meeting held Dec 5, 2024; quorum of 6.83M shares (59.2% of 11.53M outstanding shares).

## SEC filing metadata
- accession: 0001213900-24-106095
- form_type: 8-K
- ticker: TXMD
- cik: 0000025743
- company_name: TherapeuticsMD, Inc.
- filed_at: 2024-12-05T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/25743/000121390024106095/0001213900-24-106095-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/25743/000121390024106095/ea0223856-8k_therap.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-106095
- JSON: https://secwatch.observer/filing/0001213900-24-106095.json
- Plain text: https://secwatch.observer/filing/0001213900-24-106095.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.